Alpha Teknova (TKNO) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Alpha Teknova (TKNO) Net Income towards Common Stockholders Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -304.98% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.29% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 7.59% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -2,482.61% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 34.33% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 390.91% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alpha Teknova | 374.37 Mn | 356.94 Mn | 4.89 Mn | 11.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.20% |
| Mar 31, 2026 | 1.94% |
| Dec 31, 2025 | 17.35% |
| Sep 30, 2025 | 43.07% |
| Jun 30, 2025 | 33.45% |
| Mar 31, 2025 | 42.63% |
| Dec 31, 2024 | 47.82% |
| Sep 30, 2024 | 25.49% |
| Jun 30, 2024 | 25.02% |
| Mar 31, 2024 | 8.17% |
| Dec 31, 2023 | 27.88% |
| Sep 30, 2023 | 54.77% |
| Jun 30, 2023 | -15.42% |
| Mar 31, 2023 | -61.60% |
| Dec 31, 2022 | -134.36% |
| Sep 30, 2022 | -592.20% |
| Jun 30, 2022 | -175.47% |
| Mar 31, 2022 | -732.98% |
| Dec 31, 2021 | -343.12% |
| Sep 30, 2021 | -311.55% |